# PathogenDx

> PathogenDx is an Arizona biotechnology company selling multiplex molecular-testing kits, laboratory automation and analysis software. Its D3 Array platform is designed to detect, distinguish and, in some assays, quantify many microbial targets from one sample, occupying the practical middle ground between limited-target qPCR panels and slower, more expensive next-generation sequencing. The company first commercialized the platform in regulated cannabis testing and now applies it to food safety, poultry, environmental monitoring and research-use clinical panels.

- **Founded:** 2014
- **Headquarters:** Scottsdale, United States
- **Founders:** Milan Patel (Co-Founder and CEO), Michael Hogan (Co-Founder and Chief Scientific Officer), Eric Lachance (Co-Founder)
- **Team size:** Approximately 27 employees in the supplied company record; public profiles place the company in the 11-50 employee band.
- **Products:** D3 Array platform, DetectX / D3 Array Combined, QuantX, EnviroX, DetectX-Rv and DetectX-Cv
- **Notable:** Commercialized a microarray platform after roughly three years of development and validation work., Reached 100 customers and later reported partnerships with more than 120 cannabis laboratories in 36 states., Raised a $7.5 million Series B in 2019, bringing reported total equity funding to about $11.6 million.

## Products & services

- **D3 Array platform** — A patented three-dimensional, solution-facing DNA microarray architecture paired with endpoint PCR and cloud-based automated analysis; designed to multiplex many known targets in one well.
- **DetectX / D3 Array Combined** — Qualitative detection assays for regulated bacterial and fungal targets, including AOAC-validated applications in cannabis and hemp matrices.
- **QuantX** — Quantitative and semi-quantitative assays for organism classes including total yeast and mold, aerobic bacteria and related indicators.
- **EnviroX** — Environmental monitoring assays for surfaces and air, intended to trace contamination and check remediation across broad bacterial and fungal panels.
- **DetectX-Rv and DetectX-Cv** — COVID-19 respiratory detection and clade-variant testing developed with federal support; clinical claims depend on the specific assay authorization or research-use status.
- **PathogenDx Portal and Augury software** — Cloud-enabled image analysis, result tracking and automated report generation for laboratory customers.
- **Octa AutoPrep Station** — Automated sample-preparation equipment compatible with PathogenDx cannabis and hemp assays, built to reduce hands-on skilled labor.
- **D3 Array UTI** — A research-use multiplex panel for urinary pathogens and antibiotic-resistance genes.
- **Unified Salmonella Testing System** — A poultry-focused suite comprising SalSure Detect, SalSure Quant, SeroX serotyping and SalVac vaccine identification; AOAC certification was described as in progress at the January 2026 launch.

## Achievements

- Commercialized a microarray platform after roughly three years of development and validation work.
- Reached 100 customers and later reported partnerships with more than 120 cannabis laboratories in 36 states.
- Raised a $7.5 million Series B in 2019, bringing reported total equity funding to about $11.6 million.
- Received AOAC Performance Tested Method certification for QuantX Total Yeast and Mold in 2021.
- Independent AOAC studies found DetectX Combined met applicable performance requirements in cannabis and hemp matrices.
- Contributed COVID-19 and variant-testing work under NIH RADx and NIAID support.
- Launched a unified four-assay Salmonella system for poultry at IPPE in 2026, with AOAC certification in progress at launch.

## Latest updates

- **2026-01** — Launched the Unified Salmonella Testing System at IPPE, combining SalSure Detect, SalSure Quant, SeroX and SalVac for poultry processors; AOAC certification was in progress.
- **2025-03** — Added rapid-PCR inventor and BioFire co-founder Carl Wittwer to its technology and scientific advisory board.
- **2025-02** — Rebranded core cannabis assays under the D3 Array Combined, Bacterial and Fungal names.
- **2024-09** — Introduced SeroX for rapid Salmonella detection and serotyping in poultry workflows.
- **2024-04** — Introduced a research-use UTI panel for simultaneous urinary pathogen and antibiotic-resistance gene detection.
- **2023-09** — Announced the Octa AutoPrep Station for automated cannabis and hemp sample preparation.

## Links

- Website: https://pathogendx.com/
- LinkedIn: https://www.linkedin.com/company/pathogendx/
- Twitter/X: https://twitter.com/PathogenDX
- Instagram: https://www.instagram.com/pathogen_dx/
- Facebook: https://www.facebook.com/PathogenDx

---

Profile page: https://yespress.io/pathogendx
Published by YesPress — https://yespress.io
Last updated: 2026-08-22